Yüklüyor......
Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19
OBJECTIVE: Coagulopathy is one of the characteristics observed in critically ill patients with coronavirus disease 2019 (COVID‐19). Antiphospholipid antibodies (aPLs) contribute to coagulopathy, though their role in COVID‐19 remains unclear. This study was undertaken to determine the prevalence and...
Kaydedildi:
| Yayımlandı: | Arthritis Rheumatol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361932/ https://ncbi.nlm.nih.gov/pubmed/32602200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41425 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|